Nov 19 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its ...
SAN ANTONIO, Texas — Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain cancer and Alzheimer’s, potentially revolutionizing how ...
Taking a pill is the easiest, least invasive way to take medicine, but unfortunately, not all drugs work that way. Now, Stanford scientists have found “an embarrassingly simple solution” that could ...
If approved, the monthly IV maintenance regimen is expected to maintain the effectiveness of the treatment while being less burdensome for patients. The Food and Drug Administration (FDA) has accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback